These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 31041810

  • 21. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST.
    J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
    [Abstract] [Full Text] [Related]

  • 22. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
    Sun W, Feng J, Yi Q, Xu X, Chen Y, Tang L.
    Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
    [Abstract] [Full Text] [Related]

  • 23. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
    Chen L, Wu M, Ji C, Yuan M, Liu C, Yin Q.
    IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of Bmi‑1 promotes epithelial‑mesenchymal transition in CD133+Hep G2 cells.
    Zhang Z, Wang Q, Bu X, Zhang C, Chen H, Sha W, Liu W.
    Mol Med Rep; 2017 Nov; 16(5):6156-6161. PubMed ID: 28849237
    [Abstract] [Full Text] [Related]

  • 25. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
    Sun Y, Lei B, Huang Q.
    Med Sci Monit; 2019 Aug 20; 25():6244-6254. PubMed ID: 31427562
    [Abstract] [Full Text] [Related]

  • 26. Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer.
    López-Moncada F, Torres MJ, Castellón EA, Contreras HR.
    Asian J Androl; 2019 Aug 20; 21(6):557-564. PubMed ID: 31031331
    [Abstract] [Full Text] [Related]

  • 27. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
    Dou C, Jin X, Sun L, Zhang B, Han M, Li T.
    Cancer Biomark; 2017 Jul 04; 19(4):447-454. PubMed ID: 28582850
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R, Wu S, Lv X, Fang H, Wu S, Kang J.
    J Exp Clin Cancer Res; 2014 Dec 14; 33(1):105. PubMed ID: 25499255
    [Abstract] [Full Text] [Related]

  • 29. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.
    Lirdprapamongkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A, Svasti J.
    Biochem Biophys Res Commun; 2012 Jun 08; 422(3):429-35. PubMed ID: 22580004
    [Abstract] [Full Text] [Related]

  • 30. Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway.
    Zhu JN, Jiang L, Jiang JH, Yang X, Li XY, Zeng JX, Shi RY, Shi Y, Pan XR, Han ZP, Wei LX.
    Sci Rep; 2017 Jul 06; 7(1):4793. PubMed ID: 28684878
    [Abstract] [Full Text] [Related]

  • 31. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, Koudelkova P, Rani B, Fabra Á, Serrano T, Ramos E, Mikulits W, Giannelli G, Fabregat I.
    Cancer Lett; 2017 Apr 28; 392():39-50. PubMed ID: 28161507
    [Abstract] [Full Text] [Related]

  • 32. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ, Kulkarni VM.
    Eur J Med Chem; 2020 Dec 01; 207():112851. PubMed ID: 33002846
    [Abstract] [Full Text] [Related]

  • 33. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
    Wang X, Dong J, Jia L, Zhao T, Lang M, Li Z, Lan C, Li X, Hao J, Wang H, Qin T, Huang C, Yang S, Yu M, Ren H.
    Cancer Lett; 2017 May 01; 393():113-124. PubMed ID: 28153790
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Aquaporin 3 maintains the stemness of CD133+ hepatocellular carcinoma cells by activating STAT3.
    Wang Y, Wu G, Fu X, Xu S, Wang T, Zhang Q, Yang Y.
    Cell Death Dis; 2019 Jun 13; 10(6):465. PubMed ID: 31197130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.